Preoperative hepatic artery chemoembolization followed by orthotopic liver transplantation for hepatocellular carcinoma

被引:94
|
作者
Harnois, DM
Steers, J
Andrews, JC
Rubin, JC
Pitot, HC
Burgart, L
Wiesner, RH
Gores, GJ
机构
[1] Mayo Clin Rochester, Div Gastroenterol & Hepatol, Rochester, MN USA
[2] Mayo Clin Rochester, Dept Diagnost Radiol, Rochester, MN USA
[3] Mayo Clin Rochester, Div Med Oncol, Rochester, MN USA
[4] Mayo Clin Rochester, Div Anat Pathol, Rochester, MN USA
[5] Mayo Clin Jacksonville, Dept Gen Surg Liver Transplantat, Jacksonville, FL 32224 USA
来源
LIVER TRANSPLANTATION AND SURGERY | 1999年 / 5卷 / 03期
关键词
D O I
10.1002/lt.500050307
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
In our experience, the primary obstacle precluding the widespread use of orthotopic liver transplantation (OLT) for definitive therapy of hepatocellular carcinoma (HCC), even for early-stage disease, is preventing tumor recurrence. Chemoembolization is an attractive strategy to minimize tumor progression before OLT because of its shown antitumor effect, ability to be repeated, and minimal systemic toxicity, Thus, this pilot study was undertaken to determine the tolerability and treatment outcomes of pretransplantation chemoembolization of HCC followed by OLT. Between 1992 and 1997, 27 patients with HCC who had cirrhosis, no extrahepatic metastasis, less than three tumor nodules of less than 5 cm each, and no evidence of vascular invasion on preoperative imaging studies were enrolled onto the protocol. Chemoembolization was performed using Ivalon particles with mitomycin, doxorubicin, and cis-platin, Twenty-four patients completed the protocol with chemoembolization and a liver transplant. The mean United Network of Organ Sharing waiting time was 167 days, Chemoembolization was well tolerated. On examination of the explanted liver, the majority of patients had a single lesion, mean tumor size was 3.66 cm (range, 1,5 to 6 cm), and the majority of patients had stage II disease. None of the transplant recipients has developed recurrent HCC (mean follow-up, 29.2 months; range, 9 to 55 months). The 1- and 5-year disease-free survival rates are 91% and 84%, respectively. In conclusion, chemoembolization followed by OLT is well tolerated and associated with excellent outcomes in selected patients with HCC. Copyright (C) 1999 by the American Association for the Study of Liver Diseases.
引用
收藏
页码:192 / 199
页数:8
相关论文
共 50 条
  • [41] Chemoembolization followed by orthotopic liver transplant for epithelioid hemangioendothelioma
    St Peter, SD
    Moss, AA
    Huettl, EA
    Leslie, KO
    Mulligan, DC
    CLINICAL TRANSPLANTATION, 2003, 17 (06) : 549 - 553
  • [42] Hepatocellular carcinoma (HCC) in liver explants at orthotopic liver transplantation (OLT)
    Guerrero, RB
    Batts, KP
    Poterucha, JJ
    Barrett, SL
    Germer, JJ
    Wiesner, RH
    Persing, DH
    LABORATORY INVESTIGATION, 1999, 79 (01) : 160A - 160A
  • [43] Orthotopic liver transplantation in hepatocellular carcinoma: Comparison of results in incidental and known hepatocellular carcinoma
    Khan, Taqi F. Toufeeq
    Reddy, Kunam S.
    Johnston, Thomas D.
    Ranjan, Dinesh
    INTERNATIONAL SURGERY, 2006, 91 (04) : 185 - 187
  • [44] Chemoembolization followed by liver transplantation for hepatocellular carcinoma: Evaluation of antitumoral response on explanted livers and of tumor recurrence.
    Zavaglia, C
    Corso, R
    Rampoldi, A
    Vinci, M
    de Carlis, L
    Alberti, AB
    Belli, LS
    Airoldi, A
    Solcia, M
    Tringali, A
    Vangeli, M
    Vanzulli, A
    Pinzello, G
    HEPATOLOGY, 2004, 40 (04) : 298A - 299A
  • [45] Management of hepatic artery complications after orthotopic liver transplantation
    Cretin, N
    Buhler, L
    Giostra, E
    Huber, O
    Mentha, G
    Morel, P
    TRANSPLANTATION PROCEEDINGS, 1997, 29 (05) : 2414 - 2415
  • [46] THE HEPATIC-ARTERY ANASTOMOSIS IN ORTHOTOPIC LIVER-TRANSPLANTATION
    HESSELINK, EJ
    SLOOFF, MJH
    SCHUUR, KH
    DERUITER, GN
    VANDERPUTTEN, ABMM
    GIPS, CH
    TRANSPLANTATION PROCEEDINGS, 1986, 18 (05) : 1205 - 1206
  • [47] Late hepatic artery thrombosis after orthotopic liver transplantation
    Gunsar, F
    Rolando, N
    Pastacaldi, S
    Patch, D
    Raimondo, ML
    Davidson, B
    Rolles, K
    Burroughs, AK
    LIVER TRANSPLANTATION, 2003, 9 (06) : 605 - 611
  • [48] The role of complex hepatic artery reconstruction in orthotopic liver transplantation
    Soliman, T
    Bodingbauer, M
    Langer, F
    Berlakovich, GA
    Wamser, P
    Rockenschaub, S
    Muehlbacher, F
    Steininger, R
    LIVER TRANSPLANTATION, 2003, 9 (09) : 970 - 975
  • [49] ARTERIAL CHEMOEMBOLIZATION WITH MITOMYCIN-C MICROCAPSULES FOLLOWED BY TRANSCATHETER HEPATIC-ARTERY EMBOLIZATION FOR HEPATOCELLULAR-CARCINOMA
    OHNISHI, K
    SUGITA, S
    NOMURA, F
    IIDA, S
    TANABE, Y
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1987, 82 (09): : 876 - 879
  • [50] PROGRESS IN ORTHOTOPIC LIVER-TRANSPLANTATION FOR HEPATOCELLULAR-CARCINOMA
    GORES, GJ
    STEERS, JL
    GASTROENTEROLOGY, 1993, 104 (01) : 317 - 320